News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glide Pharma Secures £2.3 Million; Distribution Agreement Signed with Paladin Labs Inc. (CC:PLB)


8/15/2007 11:40:29 AM

Glide PharmaTM, the specialty pharmaceutical company developing products based on its innovative needle-free Glide SDI™ drug delivery system, has raised £2.3 million. The round involved existing shareholders, such as Oxford Technology 4 VCT, as well as new investors including Oxford Capital Partners. Under a separate agreement, Glide Pharma has also entered into an exclusive licence and distribution deal with Paladin Labs Inc, a leading Canadian specialty pharmaceutical company, for Glide Pharma products in Canada.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES